Skip to main content

Jury Selection Over Bard’s First TVM Lawsuit

Jury Selection Over Bard’s First TVM Lawsuit

Jury Selection Over Bard’s First TVM Lawsuit

Introduction

C.R. Bard, Inc. will face its first transvaginal mesh lawsuit in New Jersey before Bergen County Superior Court Judge James DeLuca. The Plaintiff is a woman who received Bard’s TVM implants to treat Pelvic Organ Prolapse (“POP”) or Stress. Urinary Incontinence that left her suffering from chronic pain. She holds Bard responsible, claiming the devices were defectively designed and manufactured.

Two cases have previously gone to trial in New Jersey, but both cases involved implants manufactured by J&J subsidiary Ethicon. Roughly 160 cases are pending that involve Bard’s implants. Since the first trial in 2012, only three cases involved C.R. Bard implants, out of which two verdicts went in favor of the plaintiff totaling to nearly $7.5 million and the third verdict was announced in favor of the defense.

Hundreds of transvaginal mesh lawsuits have been roped into confidential settlement agreements in recent years by C.R. Bard.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!